{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:33:22Z","timestamp":1761129202921},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ijid.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T07:06:26Z","timestamp":1415430386000},"page":"78-84","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Di","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Kui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"Segal","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.11.004_bib0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0015","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.ijid.2011.10.004","article-title":"The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review","volume":"16","author":"Garbati","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0030","first-page":"403","article-title":"Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients","volume":"5","author":"Conneally","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10428199209054909","article-title":"A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia","volume":"8","author":"Myers","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijid.2014.11.004_bib0040","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.37.6.1367","article-title":"Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis","volume":"37","author":"Beyer","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01739026","article-title":"Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis","volume":"22","author":"Beyer","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2014.11.004_bib0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01697981","article-title":"Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients","volume":"71","author":"Behre","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijid.2014.11.004_bib0055","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0060","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.transproceed.2010.08.013","article-title":"Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation","volume":"42","author":"Paniagua Martin","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2014.11.004_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-3062.2011.00661.x","article-title":"Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis","volume":"14","author":"Nihtinen","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01726364","article-title":"Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients","volume":"16","author":"Erjavec","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.ijid.2014.11.004_bib0080","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.32.11.1676","article-title":"Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis","volume":"32","author":"Schmitt","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/JCM.29.7.1317-1322.1991","article-title":"Model of recurrent pulmonary aspergillosis in rats","volume":"29","author":"Niki","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2014.11.004_bib0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/34.6.1001","article-title":"Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis","volume":"34","author":"Allen","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.41.2.259","article-title":"Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis","volume":"41","author":"Cicogna","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0100","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1211\/jpp.57.10.0007","article-title":"Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity","volume":"57","author":"Ruijgrok","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijid.2014.11.004_bib0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/jac\/dkr567","article-title":"Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis","volume":"67","author":"Kirkpatrick","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0110","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial","volume":"93","author":"Schwartz","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2014.11.004_bib0115","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0041-1345(96)00363-6","article-title":"Significant reduction in the number of fungal infections after lung-, heart\u2013lung, and heart transplantation using aerosolized amphotericin B prophylaxis","volume":"29","author":"Reichenspurner","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2014.11.004_bib0125","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/AAC.48.5.1908-1911.2004","article-title":"Novel inhalational murine model of invasive pulmonary aspergillosis","volume":"48","author":"Sheppard","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.00315-06","article-title":"Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model","volume":"50","author":"Olson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.11.004_bib0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/myc.12011","article-title":"Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis","volume":"56","author":"Leleu","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2014.11.004_bib0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pupt.2008.09.001","article-title":"Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial","volume":"21","author":"Slobbe","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ijid.2014.11.004_bib0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000327802","article-title":"Prophylactic application of nebulized liposomal amphotericin B in hematologic patients with neutropenia","volume":"34","author":"Hullard-Pulstinger","year":"2011","journal-title":"Onkologie"},{"key":"10.1016\/j.ijid.2014.11.004_bib0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2008.11.004","article-title":"Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety","volume":"28","author":"Monforte","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0160","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2014.11.004_bib0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijid.2014.11.004_bib0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation\u2014a world-wide survey","volume":"11","author":"Neoh","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijpharm.2012.07.028","article-title":"Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization","volume":"436","author":"Nasr","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijid.2014.11.004_bib0185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2012.04.004","article-title":"The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection","volume":"160","author":"Alsaadi","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.ijid.2014.11.004_bib0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tid.12071","article-title":"Preemptive treatment with voriconazole in lung transplant recipients","volume":"15","author":"Neoh","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients","volume":"44","author":"Tofte","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2014.11.004_bib0200","first-page":"399","article-title":"Fungal infection in heart\u2013lung transplant recipients receiving single-agent prophylaxis with itraconazole","volume":"9","author":"Hayes","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.ijid.2014.11.004_bib0205","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/AAC.01657-08","article-title":"Inhaled voriconazole for prevention of invasive pulmonary aspergillosis","volume":"53","author":"Tolman","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T16:09:17Z","timestamp":1598458157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214016853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":41,"alternative-id":["S1201971214016853"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.11.004","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}